DeLuca Teresa's Form 4/A amendment
AmendedSurgery Partners, Inc. (SGRY) · filed Aug 20, 2026
- Accession no.
- 0001638833-26-000081
- Filed
- Aug 20, 2026, 6:10 PM ET
- Trade date
- Aug 18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 19, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $161.2K. It was filed 2 days after the trade.
This amendment replaces 0001638833-26-000079 (filed Aug 19, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DeLuca TeresaCIK 0001685627 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | PPurchaseAcquired | +11,250 | $14.33F1 | +$161,212.5 | 68,093 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
This Form 4/A amends the Form 4 originally filed on August 19, 2026 to correct the number of shares of the Issuer's common stock purchased by the Reporting Person and the purchase price per share reported in Table I. The original Form 4 inadvertently reported the purchase of 10,000 shares at a price of $14.35 per share. The Reporting Person actually purchased 11,250 shares at a price of $14.33 per share. The amount of securities beneficially owned following the transaction has been corrected accordingly. Except as set forth herein, the original Form 4 remains unchanged.